标题
Anti-MUC1 aptamer: A potential opportunity for cancer treatment
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume 37, Issue 6, Pages 1518-1539
出版商
Wiley
发表日期
2017-07-31
DOI
10.1002/med.21462
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-MUC1 Aptamer/Negatively Charged Amino Acid Dendrimer Conjugates for Targeted Delivery to Human Lung Adenocarcinoma A549 Cells
- (2016) Marie Masuda et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- A FRET-guided, NIR-responsive bubble-generating liposomal system for in vivo targeted therapy with spatially and temporally precise controlled release
- (2016) Er-Yuan Chuang et al. BIOMATERIALS
- Preparation and evaluation of polyethylenimine-functionalized carbon nanotubes tagged with 5TR1 aptamer for targeted delivery of Bcl-xL shRNA into breast cancer cells
- (2016) Sahar Taghavi et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer
- (2016) Morteza Azhdarzadeh et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas
- (2016) W. Fiedler et al. EUROPEAN JOURNAL OF CANCER
- Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo
- (2016) Seyed Mohammad Taghdisi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A quantum dot–MUC1 aptamer conjugate for targeted delivery of protoporphyrin IX and specific photokilling of cancer cells through ROS generation
- (2016) Seema Singh et al. Integrative Biology
- Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer
- (2016) Mehdi Esfandyari-Manesh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Enhancement of Thermal Damage to Adenocarcinoma Cells by Iron Nanoparticles Modified with MUC1 Aptamer
- (2016) Fangqin Guo et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
- (2016) Elisabeth Quoix et al. LANCET ONCOLOGY
- Biocompatible ELR-Based Polyplexes Coated with MUC1 Specific Aptamers and Targeted for Breast Cancer Gene Therapy
- (2016) Maria J. Piña et al. MOLECULAR PHARMACEUTICS
- MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
- (2016) Vani Lakshminarayanan et al. PLoS One
- Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro
- (2016) Bindong Dai et al. Oncotarget
- Photothermal Therapeutic Response of Cancer Cells to Aptamer–Gold Nanoparticle-Hybridized Graphene Oxide under NIR Illumination
- (2015) Lingyan Yang et al. ACS Applied Materials & Interfaces
- Trends in aptamer selection methods and applications
- (2015) Meral Yüce et al. ANALYST
- Replacing antibodies with aptamers in lateral flow immunoassay
- (2015) Ailiang Chen et al. BIOSENSORS & BIOELECTRONICS
- Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas
- (2015) Zahra Ghasemi et al. CARBOHYDRATE POLYMERS
- In vitro investigation of methylene blue-bearing, electrostatically assembled aptamer–silica nanocomposites as potential photodynamic therapeutics
- (2015) Tian-Shyng Ding et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core–shell nanoparticles
- (2015) Behrang Shiri Varnamkhasti et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Mucins in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Implications
- (2015) Imayavaramban Lakshmanan et al. Journal of Thoracic Oncology
- Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics
- (2015) John Bruno MOLECULES
- Aptamer density dependent cellular uptake of lipid-capped polymer nanoparticles for polyvalent targeted delivery of vinorelbine to cancer cells
- (2015) Zhenbao Liu et al. RSC Advances
- Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy
- (2015) Xu Wu et al. Theranostics
- Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients
- (2014) Lior Carmon et al. BRITISH JOURNAL OF HAEMATOLOGY
- MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery
- (2014) E. Sayari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
- (2013) Junli Deng et al. CANCER AND METASTASIS REVIEWS
- Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo
- (2013) Seyed Hamid Jalalian et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The anti-chemoresistant effect and mechanism of MUC1 aptamer–miR-29b chimera in ovarian cancer
- (2013) Furong Dai et al. GYNECOLOGIC ONCOLOGY
- Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
- (2013) D Raina et al. ONCOGENE
- MUC1 and metastatic cancer
- (2013) Teresa M. Horm et al. Cell Adhesion & Migration
- PEGylation and Biodistribution of an anti-MUC1 Aptamer in MCF-7 Tumor-Bearing Mice
- (2012) Chiara Da Pieve et al. BIOCONJUGATE CHEMISTRY
- Designer Tridentate Mucin 1 Aptamer for Targeted Drug Delivery
- (2012) Lihan Tan et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Development of Nanoaptamers Using a Mesoporous Silica Model Labeled with 99mTc for Cancer Targeting
- (2012) Lucas Torres Miranda Sá et al. ONCOLOGY
- Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro
- (2012) Yan Hu et al. PLoS One
- Interactions of aptamers with sera albumins
- (2012) Célia Martins Cortez et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Anticancer role of MUC1 aptamer–miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation
- (2012) Furong Dai et al. Targeted Oncology
- Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer Therapy
- (2011) Microsugar Chang et al. ACS Nano
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer
- (2011) N. K. Ibrahim et al. CLINICAL CANCER RESEARCH
- Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer
- (2011) Tomoaki Kurosaki et al. GENE
- Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
- (2011) Ronak Savla et al. JOURNAL OF CONTROLLED RELEASE
- PEGylated Anti-MUC1 Aptamer-Doxorubicin Complex for Targeted Drug Delivery to MCF7 Breast Cancer Cells
- (2011) Lihan Tan et al. MACROMOLECULAR BIOSCIENCE
- Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro
- (2011) Chenchen Yu et al. PLoS One
- MUC1 expression and its association with other aetiological factors and localization to mitochondria in preneoplastic and neoplastic gastric tissues
- (2010) J.B. Elisha Benjamin et al. CLINICA CHIMICA ACTA
- Emerging applications of multifunctional elastin-like recombinamers
- (2010) J Carlos Rodríguez-Cabello et al. Nanomedicine
- Development of DNA aptamers using Cell-SELEX
- (2010) Kwame Sefah et al. Nature Protocols
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
- (2010) L D Roy et al. ONCOGENE
- The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers
- (2009) Nicolas Jonckheere et al. BIOCHIMIE
- MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
- (2009) R. Garzon et al. BLOOD
- MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells
- (2009) Shawn P. Fessler et al. BREAST CANCER RESEARCH AND TREATMENT
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Aptamer–biotin–streptavidin–C1q complexes can trigger the classical complement pathway to kill cancer cells
- (2009) John Gordon Bruno IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Anti-MUC1 aptamers: radiolabelling with 99mTc and biodistribution in MCF-7 tumour-bearing mice
- (2009) Chiara Da Pieve et al. NUCLEAR MEDICINE AND BIOLOGY
- Intracellular MUC1 Peptides Inhibit Cancer Progression
- (2008) B. G. Bitler et al. CLINICAL CANCER RESEARCH
- The MUC1 oncoprotein as a functional target: Immunotoxin binding to α/β junction mediates cell killing
- (2008) Daniel B. Rubinstein et al. INTERNATIONAL JOURNAL OF CANCER
- Phototoxic aptamers selectively enter and kill epithelial cancer cells
- (2008) Cátia S. M. Ferreira et al. NUCLEIC ACIDS RESEARCH
- MUC1* Mediates the Growth of Human Pluripotent Stem Cells
- (2008) Sherry T. Hikita et al. PLoS One
- Structure and Function of the Cell Surface (Tethered) Mucins
- (2007) Christine L. Hattrup et al. Annual Review of Physiology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started